EGFR and lung cancer: Treatment of EGFR-addicted lung cancer cells, PC-9 and A549 with miR-133b mimic inhibited phosphorylation of EGFR, AKT, and extracellular signal-related kinase (ERK)1/2, thus inhibiting their growth and invasion abilities.